Patients undergoing hemodialysis have an annual mortality rate exceeding 20%, comparable to many types of cancer. Past research has shown that patients with cancer overestimate their likelihood of survival relative to their physicians, but this relationship has not been examined in patients with noncancer diagnoses. Perceptions of prognosis and transplant candidacy may influence goals of care.
E nd-stage renal disease is a significant cause of morbidity and mortality in the United States. Approximately 400 000 Americans currently undergo long-term dialysis, 1 and the 1-year mortality rate for these patients ranges from 20% to 25%, 2 comparable to that of many types of can-
cer. An accurate estimate of prognosis enables patients and families to plan for the future and make informed decisions about goals of care. 3 We therefore believe that physicians should offer to discuss prognosis with patients, particularly those who are seriously ill. 4 Several studies [5] [6] [7] [8] have documented that patients with cancer commonly overestimate their likelihood of survival relative to their physicians. However, this occurrence has not been studied in patients with noncancer diagnoses. Therefore, whether these findings translate to patients with other endstage conditions, such as end-stage renal disease, is unknown. Although prognostication can be more difficult for noncancer diagnoses, 9 validated prognostic instruments exist to estimate mortality risk for a number of patient populations, including those undergoing hemodialysis. [10] [11] [12] [13] [14] [15] [16] [17] In 2000, the Renal Physicians Association and the American Society of Nephrology issued a joint practice guideline 18 recommending that providers communicate the likelihood of survival to all hemodialysis patients. An updated guideline 19 was issued in 2010.
To assist physicians in calculating survival estimates for individual hemodialysis patients, the guideline cites validated prognostic tools. 19 However, the extent to which nephrologists have conversations with hemodialysis patients about prognosis is unknown. One factor that may affect prognosis in end-stage renal disease and dialysis-related decision making is the possibility of kidney transplant. Transplant recipients have a 68% lower mortality rate than patients eligible for transplant who continue to receive hemodialysis. 20 The degree to which patients and nephrologists agree about the likelihood of transplant remains unknown. Finally, we do not know whether the expectations that seriously ill hemodialysis patients have about prognosis and transplant candidacy influence their goals of care. We sought to compare the perceptions of prognosis and likelihood of transplant among hemodialysis patients and their nephrologists, to follow actual patient survival, and to explore the relationship between patients' expectations and their goals of care.
Methods

Design Overview
We conducted a 2-part study of patients receiving maintenance hemodialysis. Part 1 consisted of a medical record abstraction and a physician screening question to estimate the risk of 1-year mortality for all patients. Part 2 consisted of inperson interviews with seriously ill hemodialysis patients (defined as having a ≥20% risk of dying in the next year) and their nephrologists. Our cut point of 20% or greater is supported by the nephrology societies' practice guideline, 18,19 which recommends discussing temporally specific prognostic estimates with all hemodialysis patients. Human subjects committees at both hospitals and dialysis units approved the study.
Setting and Participants
We included patients from 2 community-based hemodialysis units affiliated with tertiary care medical centers in Boston from November 1, 2010, through September 1, 2011. The Figure shows the construction of our sample. We began with all 227 patients on the hemodialysis centers' rosters, of whom 207 had adequate documentation in their medical record to estimate 1-year mortality risk using 2 prognostic indices (described below). Among these 207 patients, 150 (72.5%) had an estimated 1-year mortality risk that was 20% or greater on at least 1 index, which we defined as seriously ill. We then applied exclusion criteria to these 150 patients to identify those eligible for our interview. Seventy of these patients (46.7%) were excluded owing to cognitive impairment (n = 23), inability to speak English (n = 21), or other factors (n = 26) (Figure) . Of the remaining 80 eligible patients, 62 provided informed consent and were interviewed (response rate, 78%).
Medical Record Abstraction and Physician Screening Question
We collected information from the patients' medical records on sociodemographic characteristics, medical comorbidities, use of health care resources, and albumin concentrations. We used the following 2 validated prognostic models 11, 13 Study. 26 We assessed patients' prognostic expectations by asking what they thought their chances were of being alive in 1 and 5 years, respectively (≥90%, about 75%, about 50%, about 25%, ≤10%, or don't know). Nephrologists were asked to estimate each patient's likelihood of being alive at 1 and 5 years on a continuous scale from 0 to 100%. We also asked patients and nephrologists whether they thought kidney transplant was a possibility and what they thought their likelihood of receiving a transplant was (using the same multiple-choice options as for estimates of prognosis). We defined "optimistic transplant discordance" as present when patients reported a greater likelihood than their nephrologists that they would receive a transplant. Patients' goals of care were assessed by using the item, "If you were seriously ill, would you prefer care to (a) extend life, even if it meant more pain and discomfort, or (b) relieve pain and discomfort, even it if meant not living as long?" For each patient, nephrologists were asked to estimate life expectancy and to report whether they had provided an estimate to the patient. If not, they were asked whether they would communicate a specific estimate if the patient insisted on receiving one.
Abstraction of Survival Data
We obtained survival data through December 20, 2012, from the hemodialysis units. One unit recorded the date of death, whereas the other recorded only the month of death, in which case we set the date as the 15th of the month. We also obtained the last date of hemodialysis for any patient who was no longer receiving hemodialysis at the unit.
Statistical Analysis
Using the prognostic calculators, 11, 13 we compared characteristics between patients with at least a 20% and those with less than a 20% projected 1-year mortality. Next, we examined the 150 patients with a 1-year mortality risk of 20% or greater, comparing those who participated in the interview (n = 62), who met exclusion criteria (n = 70), and who refused participation (n = 18). Our subsequent analyses focused on the 62 patients we interviewed. We examined how often patients and nephrologists reported that prognostic discussions occurred, and we assessed nephrologists' willingness to formulate and communicate prognostic estimates to their patients. Consistent with previous research, 8 we grouped physicians' 1-and 5-year survival estimates into 5 categories to facilitate comparisons with patients' estimates. We assessed agreement between patients' and their nephrologists' prognostic estimates with the weighted κ statistic and the Spearman correlation coefficient (r s ) and between their beliefs about transplant candidacy with the κ statistic. We used the McNemar test to assess whether the disagreement between patients' and nephrologists' estimates was in a particular direction. We counted the number of patients with more optimistic estimates than their physicians and the number with more pessimistic estimates. As a sensitivity analysis, we repeated the analysis but required disagreement by at least 2 categories (ie, ≥90%, 61%-89%, 40%-60%, 11%-39%, and ≤10%). Next, we dichotomized patients' survival estimates as 90% or greater or less than 90% and used Fisher exact tests to explore whether patients' prognostic expectations and the presence of optimistic transplant discordance were associated with their goals of care. We excluded patients with item nonresponse from those analyses for which data were missing (ranging from 3 to 10). Finally, we estimated actual survival with the KaplanMeier product-limit method. We conducted all data analyses with commercially available software (SAS, version 9.2; SAS Institute, Inc).
Results Table 1 shows characteristics of the 207 patients in our medical record review, comparing patients with a predicted 1-year mortality risk of at least 20% and those with a risk of less than 20%. Patients with a higher mortality risk were older (mean ages, 70.2 vs 48.4 years) and had a greater comorbid disease burden. Their nephrologists were also less likely to report that they would be surprised if the patient died in the next 6 months (53.4% vs 96.3%). Table 2 presents characteristics of the 150 patients with a 1-year mortality risk of 20% or greater, comparing eligible patients who were interviewed, eligible patients who refused participation, and ineligible patients. Ineligible patients were more frequently Hispanic. Interviewees were younger and less likely to have dementia than those who were ineligible or refused. Nephrologists of ineligible patients were the least likely to be surprised if the patient died in the next 6 months (40%). The groups were otherwise similar.
Among the 62 interviewed patients, no patients reported that their nephrologist had discussed an estimate of life expectancy with them, and the nephrologists reported that they had done so for only 2 interviewed patients (3%). Nephrologists provided us with estimates of life expectancy for 55 of the interviewed patients (89%) but reported that, if the patient insisted on an estimate, they would refuse to provide any estimate for 33 of these (60%). Table 3 summarizes patients' and nephrologists' expectations about survival. We found almost no agreement between patients' and nephrologists' estimates of 1-year survival (weighted κ = 0.08; r s = 0.09), 27 with patients significantly more optimistic than their nephrologists (P < .001). Patients' estimates were more optimistic in 38 of 59 patientnephrologist pairs (64%), whereas nephrologists were more optimistic in 6 of 59 pairs (10%). Overall, 81% of patients thought they had at least a 90% chance of being alive in 1 year, whereas nephrologists were this optimistic for only 25% of patients. The lack of patient-nephrologist agreement (weighted κ = 0.13; r s = 0.16) and the finding that patients were significantly more optimistic (P < .001) were similar for 5-year estimates. Patients' estimates were more optimistic in 36 of 52 patientnephrologist pairs (69%), whereas nephrologists were more optimistic in 1 of 52 pairs (2%). Only 6% of patients thought they had less than a 50% chance of being alive in 5 years, whereas nephrologists estimated that 56% of the patients had a chance of 5-year survival at less than 40%. For 1-and 5-year survival, sensitivity analyses requiring 2 categories of disagreement showed the same pattern (P < .001 for both). Table 4 indicates that the degree of agreement between patients' and nephrologists' beliefs about transplant candidacy was only fair (κ = 0.35). 27 Patients were significantly more likely than their nephrologists to report that they were transplant candidates (66% vs 39% [P = .008]), and 12 of 29 patients (41%) whose nephrologists said were not transplant candidates believed they were. Overall, optimistic transplant discordance was present in 24 of 57 patient-nephrologist pairs (42%). Table 5 presents results for patients' goals of care. Overall, 54% reported that, if they were seriously ill, they would want care focused on relieving pain and discomfort rather than extending life. Patients who thought they had a 90% chance or greater of being alive in 1 year were significantly more likely to prefer life-extending care than were those who reported a less than 90% chance (44% vs 9% [P = .045]). Patients who were more optimistic than their nephrologist about transplant likelihood were also more likely to report a preference for lifeextending care (55% vs 23% [P = .054]).
The Kaplan-Meier survival curve for the 62 interviewed patients is shown in the eFigure in the Supplement. Survival was 93% at 1 year but decreased to 79% by 17 months and 56% by 23 months.
Discussion
In our study using interviews with 62 patients and their nephrologists, we found that seriously ill hemodialysis patients were significantly more optimistic than their nephrologists about their prognosis and transplant candidacy. In our sample, patients' expectations about 1-year survival were more accurate than those of their nephrologists, whereas patients' longerterm survival expectations dramatically overestimated even their 2-year survival rates. Only 6% of patients thought they 
a Data are expressed as the number (percentage) of patient-nephrologist pairs.
b Assessed as response to the question, "What do you think the chances are that
[patient] will be alive in 1 year and 5 years?" Nephrologists provided a specific estimate for each of their patients. c Assessed as response to the question, "What do you think the chances are that you will be alive in 1 year?" Overall, 59 pairs underwent analysis, excluding 3 pairs for whom data were missing for the patient's estimate (of whom 2 were also missing data for the nephrologist's estimate) (weighted κ for patient-nephrologist agreement, 0.08; r s = 0.09 [P < .001, McNemar test for primary and sensitivity analyses]). d Assessed as response to the question, "What do you think the chances are that you will be alive in 5 years?" Overall, 52 pairs underwent analysis, excluding 6 pairs for whom data were missing for the patient's response, 2 pairs for whom data were missing for the nephrologist's response, and 2 pairs for whom data were missing for both (weighted κ for patient-nephrologist agreement, 0. had less than a 50% chance of being alive in 5 years, whereas actual survival at just less than 2 years of follow-up was only 56%. Meanwhile, nephrologists estimated that more than half the patients had a likelihood of 5-year survival below 40%, supporting the assertion that nephrologists were more accurate than patients about longer-term survival. Furthermore, more than one-third of patients whose nephrologists said they were not transplant candidates believed they were. Our finding that seriously ill hemodialysis patients overestimate their chances of survival compared with their physicians has been observed in patients with cancer [5] [6] [7] [8] and in surrogate decision makers for patients in intensive care units 28-34 but has never been studied in patients with noncancer diagnoses. That hemodialysis patients and their nephrologists had discordant views about prognosis is not surprising because we found that not a single patient reported receiving an estimate of life expectancy from a nephrologist and that nephrologists reported having given such estimates to only 2 patients. Our findings are consistent with a Canadian study in which fewer than 10% of hemodialysis patients reported that their nephrologist had discussed prognosis. 35 That study also found that more than 90% of patients with advanced kidney disease wanted prognostic information. However, although many patients want their physician to discuss prognosis with them, another study found that 25% of elderly patients did not. 36 Therefore, clinicians should always elucidate a patient's preferences before sharing prognostic estimates. Perhaps of greater concern is our finding that nephrologists reported that, for 60% of patients, they would not provide any estimate of prognosis even if their patient insisted. This percentage of nondisclosure is higher than the percentage documented in the cancer literature 37 and suggests that nephrologists may be even more reluctant to discuss prognosis with their hemodialysis patients than physicians caring for patients with cancer. Recent qualitative work 38 found that lack of confidence in predictions and concern about upsetting patients were barriers to nephrologists' discussing prognosis; this issue deserves further research to design effective interventions to improve communication.
Our finding that patients are more optimistic than their nephrologists about the likelihood of transplant is a novel contribution to the literature and has important implications. Previous research comparing patients' and physicians' expectations about prognosis has focused on patients with cancer, for whom solid-organ transplant is not a treatment option. In contrast, for some seriously ill hemodialysis patients, a kidney transplant may be possible, and kidney transplant has been shown to improve their prognosis. 20 Patients should have an accurate understanding of their likelihood of transplant, so they can make informed medical decisions. Our findings raise the possibility that patients may be making medical decisions based on an inaccurate assumption that they are likely to receive a kidney transplant. More than half of patients interviewed stated that if they were seriously ill they would choose care focused on relieving pain and discomfort, even if it meant not living as long. Among those who thought their chance of being alive in 1 year was at least 90%, about half indicated a preference for comfort-focused care compared with nearly all patients who thought their chance was less than 90%. Previous work 35,39,40 exploring treatment preferences for end-of-life care among patients with advanced kidney disease did not examine the association between prognostic expectations and goals of care. Our findings therefore have additional implications. First, because patients' beliefs about prognosis were associated with their goals of care, sharing prognostic information with patients may affect medical decision making. Second, because more than half the interviewed patients indicated a preference for comfort-focused care if they were seriously ill, hemodialysis patients generally may receive more aggressive care at the end of life than they desire. Our study has important limitations. First, our sample was limited to patients from 2 hemodialysis units affiliated with academic medical centers, which may limit generalizability. Second, our sample was relatively small, in large part because almost half the patients with a predicted 1-year mortality of 20% or greater met exclusion criteria, most commonly owing to cognitive impairment. Conversations about prognosis are arguably even more important with cognitively impaired patients and their health care proxies, who often face difficult treatment decisions toward the end of life. Therefore, future research exploring expectations and beliefs among the proxies of such patients would be valuable. Hispanic patients also made up a disproportionate share of excluded patients, and it is unclear whether our findings would be similar among Spanish-speaking patients. Nonetheless, our interview participation rate was 78%, which is quite high for a study involving in-depth interviews with seriously ill patients.
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Another limitation is that prognostic indices may be inaccurate for individual patients. Also of note, our survival data are based on hemodialysis unit-recorded deaths. These data could bias our survival estimates upward because deaths of patients who were no longer receiving hemodialysis at the units are not reflected in our data.
In addition, patients were asked about their goals of care if they were seriously ill, and hypothetical preferences may not reflect actual future preferences or use of aggressive care. Finally, although perceived prognosis was associated with goals of care, this association cannot be interpreted as causal. Certain types of patients may be predisposed to be more optimistic about prognosis and to prefer life-extending care independent of their prognostic optimism, in which case discussions about prognosis may not modify their decision making.
Conclusions
Our study suggests that seriously ill hemodialysis patients are more optimistic than their nephrologists about their prognosis and the likelihood of transplant and that nephrologists rarely disclose prognostic estimates to patients. In our sample, patients' optimistic survival expectations were not inconsistent with actual survival at 1 year. However, between 1 and 2 years, actual survival rapidly declined, and patients' expectations became markedly overoptimistic. The ability to accurately estimate prognosis in patients with noncancer diagnoses is increasingly being recognized as critical to patient-centered decision making, 4 and a number of prognostic indices with good predictive properties exist for end-stage renal disease. 13, 16, 17 As our ability to accurately prognosticate for seriously ill patients continues to advance, developing interventions to help providers communicate effectively with patients about prognosis will become increasingly important.
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